Complications of Antibiotic Therapy

Medical Clinics of North America

Volumn 97, Issue 4, 2013, Pages 667-679

  Wright, Jenny ^a,b   Paauw, Douglas S ^b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotics; Drug interactions; Drug induced lupus; Side effects

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; COLISTIN; COTRIMOXAZOLE; DAPSONE; DOXYCYCLINE; ERYTHROMYCIN; ISONIAZID; LINEZOLID; MACROLIDE; METRONIDAZOLE; MINOCYCLINE; MOXIFLOXACIN; NAFCILLIN; NITROFURANTOIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; RIFAMPICIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG; VANCOMYCIN; WARFARIN;

ACALCULOUS CHOLECYSTITIS; AGRANULOCYTOSIS; ALLERGIC REACTION; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC THERAPY; APLASTIC ANEMIA; ARTHRALGIA; AUTOIMMUNE HEMOLYTIC ANEMIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBELLUM DISEASE; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; COUGHING; CYSTITIS; DELIRIUM; DRESS SYNDROME; DRUG ERUPTION; DRUG FATALITY; DYSPNEA; EOSINOPHILIA; ERYTHROCYTE SEDIMENTATION RATE; ESOPHAGITIS; FATIGUE; FEVER; HALLUCINATION; HEMOLYTIC ANEMIA; HUMAN; HYPERKALEMIA; HYPERTRANSAMINASEMIA; INTERSTITIAL NEPHRITIS; KIDNEY INJURY; LIVER DISEASE; LIVER TOXICITY; LUNG TOXICITY; LUPUS LIKE SYNDROME; MALAISE; MYALGIA; ODYNOPHAGIA; OPTIC NEURITIS; PERICARDITIS; PERIPHERAL NEUROPATHY; PHOTOSENSITIVITY; PLEURISY; PRESCRIPTION; PRIORITY JOURNAL; PURE RED CELL ANEMIA; QT PROLONGATION; RASH; RECURRENT DISEASE; RETINA DETACHMENT; REVIEW; RISK ASSESSMENT; SEIZURE; SEROTONIN SYNDROME; SIDE EFFECT; SKIN ALLERGY; STEVENS JOHNSON SYNDROME; SUDDEN CARDIAC DEATH; TENDINITIS; TENDON RUPTURE; THORAX PAIN; THROMBOCYTOPENIA; TORSADE DES POINTES; TOXIC EPIDERMAL NECROLYSIS; TOXIC HEPATITIS; URINARY TRACT INFECTION; VAGINA CANDIDIASIS;

ANTI-BACTERIAL AGENTS; DRUG INTERACTIONS; HUMANS;

EID: 84879781020     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2013.02.006     Document Type: Review

References (49)

1. Garratty G. Immune hemolytic anemia associated with drug therapy. Blood Rev 2010, 24(4-5):143-150.
2. Young N.S. Acquired aplastic anemia. Ann Intern Med 2002, 136(7):534-546.
3. Available at: last accessed 11/1/2012. http://www.ouhsc.edu/platelets/ditp.html.
4. van der Klauw M.M., Goudsmit R., Halie M.R., et al. Apopulation-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med 1999, 159(4):369-374.
5. Andersohn F., Konzen C., Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 2007, 146(9):657-665.
6. Cunha B.A. Antibiotic side effects. Med Clin North Am 2001, 85(1):149-185.
7. Ray W.A., Murray K.T., Hall K., et al. Azithromycin and the risk of cardiovascular death. NEngl J Med 2012, 366:1881-1890.
8. Bril F., Gonzalez C.D., Di Girolamo G. Antimicrobial agents associated with QT interval prolongation. Curr Drug Saf 2010, 5(1):85-92.
9. Lapi F., Wilchesky M., Kezouh A., et al. Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis 2012, 55(11):1457-1465.
10. Vahid B., Wildemore B.M. Nitrofurantoin pulmonary toxicity: a brief review. Internet J Pulm Med 2006, 6(2).
11. Bartlett J.G. Clinical practice. Antibiotic-associated diarrhea. NEngl J Med 2002, 346(5):334-339.
12. Hempel S., Newberry S.J., Maher A.R., et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012, 307(18):1959-1969.
13. Available at: http://webedition.sanfordguide.com.
14. Gröchenig H.P., Tilg H., Vogetseder W. Clinical challenges and images in GI. Pill esophagitis. Gastroenterology 2006, 131(4):996. 1365.
15. Leitner J.M., Graninger W., Thalhammer F. Hepatotoxicity of antibacterials: pathomechanisms and clinical data. Infection 2010, 38:3-11.
16. Carson J.L., Strom B.L., Duff A., et al. Acute liver disease associated with erythromycins, sulfonamides, and tetracyclines. Ann Intern Med 1993, 119(7 Pt 1):576-583.
17. Wong-Beringer A., Joo J., Tse E., et al. Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy. Int J Antimicrob Agents 2011, 37(2):95-101.
18. Perazella M.A., Markowitz G.S. Drug-Induced acute interstitial nephritis. Nat Rev Nephrol 2010, 6:461-470.
19. Antoniou T., Gomes T., Juurlink D.N., et al. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system. Arch Intern Med 2010, 170(10):1045-1049.
20. Antoniou T., Gomes T., Mamdani M.M., et al. Trimethoprim-sulfamethoxazole induced hyperkalemia in elderly patients receiving spironolactone: nested case-control study. BMJ 2011, 343:d5228.
21. Zietse R., Zoutendijk R., Hoorn E.J. Fluid, electrolyte and acid-base disorders associated with antibiotic therapy. Nat Rev Nephrol 2009, 5(4):193-202.
22. Mohr J.A., Clark R.M., Waack T.C., et al. Nafcillin-associated hypokalemia. JAMA 1979, 242(6):544.
23. Xu J., Schwartw K. Effect of antibiotics on vulvovaginal candidiasis: a MetroNet Study. JAm Board Fam Med 2008, 21:261-268.
24. Pirotta M.V., Garland S.M. Genital candida species detected from women in Melbourne, Australia, before and after treatment with antibiotics. JClin Microbiol 2006, 44:3212-3217.
25. Pirotta M., Gunn J., Chondros P., et al. Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial. BMJ 2004, 329(7465):548.
26. Falagas M.E., Betsi G.I., Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. JAntimicrob Chemother 2006, 58(2):266-272.
27. Borchers A.T., Keen C.L., Gershwin M.E. Drug-induced lupus. Ann N Y Acad Sci 2007, 1108:166-182.
28. Diaz L., Ciurea A.M. Cutaneous and systemic adverse reactions to antibiotics. Dermatol Ther 2012, 25(1):12-22.
29. Cacoub P., Musette P., Descamps V., et al. The DRESS syndrome: a literature review. Am J Med 2011, 124(7):588-597.
30. Usatine R.P., Sandy N. Dermatologic emergencies. Am Fam Physician 2010, 82(7):773-780.
31. Romano A., Guéant-Rodriguez R.M., Viola M., et al. Cross-reactivity and tolerability of cephalosporins in patients with immediate hypersensitivity to penicillins. Ann Intern Med 2004, 141(1):16-22.
32. Vassileva S.G., Mateev G., Parish L.C. Antimicrobial photosensitive reactions. Arch Intern Med 1998, 158(18):1993-2000.
33. Agbaht K., Bitik B., Piskinpasa S., et al. Ciprofloxacin-associated seizures in a patient with underlying thyrotoxicosis: case report and literature review. Int J Clin Pharmacol Ther 2009, 47(5):303-310.
34. Tomé A.M., Filipe A. Quinolones: review of psychiatric and neurological adverse reactions. Drug Saf 2011, 34(6):465-488.
35. Catic A.G. Identification and management of in-hospital drug-induced delirium in older patients. Drugs Aging 2011, 28(9):737-748.
36. Wise B.L., Peloquin C., Choi H., et al. Impact of age, sex, obesity and steroid use on quinolone-associated tendon rupture. Am J Med 2012, 125:1228.e23-1228.e28.
37. Etminan M., Forooghian F., Brophy J.M., et al. Oral fluoroquinolones and the risk of retinal detachment. JAMA 2012, 307(13):1414-1419.
38. Clark D.B., Andrus M.R., Byrd D.C. Drug Interactions between linezolid and selective serotonin reuptake inhibitors: case reports involving sertraline and review of the literature. Pharmacotherapy 2006, 26(2):269-276.
39. Baillargeon J., Holmes H.M. Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults. Am J Med 2012, 125:183-189.
40. Glasheen J.J., Fugit R.V., Prochazka A.V. The risk of overanticoagulation with antibiotic use in outpatients on stable warfarin regimens. JGen Intern Med 2005, 20:653-656.
41. Fischer H.D., Juurlink D.N., Mamdani M.M., et al. Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents. Arch Intern Med 2010, 170(7):617-621.
42. Bourre-tessier J., Haraoui B. Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review. JRheumatol 2010, 37:1416-1421.
43. Ho J.M., Juurlink D.N. Considerations when prescribing trimethoprim-sulfamethoxazole. CMAJ 2011, 183(16):1851-1858.
44. Juurlink D.N., Mamdani M., Kopp A., et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003, 289:1652-1658.
45. Baciewicz A.M., Chrisman C.R., Finch C.K., et al. Update on rifampin, rifabutin, and rifapentine drug interactions. Curr Med Res Opin 2013, 29:1-12.
46. Archer J.S., Archer D.F. Oral contraceptive efficacy and antibiotic interaction: a myth debunked. JAm Acad Dermatol 2002, 46:917-923.
47. Toh S., Mitchell A.A., Anderka M., et al. Antibiotics and oral contraceptive failure-a case-crossover study. Contraception 2011, 83:418-425.
48. Dickinson B.D., Altman R.D., Nielsen N.H., et al. Drug interactions between oral contraceptives and antibiotics. Obstet Gynecol 2001, 98:853-860.
49. Visapaa J.P., Tillonen J.S., Kaihavaara P.S., et al. Lack of disulfiram-like reaction with metronidazole and ethanol. Ann Pharmacother 2002, 36:971-974.